PhRMA, BIO Support Expanding Vaccines For Children Program To Underinsured
This article was originally published in The Pink Sheet Daily
The industry trade associations advocated their positions during a National Vaccine Program Office stakeholders forum. A pending Senate bill would expand the program while also removing pre-1993 vaccine price caps.
You may also be interested in...
The meningococcal conjugate vaccine will be provided as catch up to 11- to 18-year-olds depending on supply. CDC projects the cost of the vaccine, which could be approved this year, at $80 per dose.
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.